AMENDMENT NUMBER ONE TO CREDIT AGREEMENT AND WAIVERCredit Agreement • April 1st, 2022 • Glass House Brands Inc. • Medicinal chemicals & botanical products
THIS AMENDMENT NUMBER ONE TO CREDIT AGREEMENT AND WAIVER (this “Amendment”), dated as of January 21, 2022, is entered into by and among the lenders identified on the signature pages hereof (each of such lenders, together with its successors and permitted assigns, is referred to hereinafter as a “Lender”, as that term is hereinafter further defined), [REDACTED NAME OF US-BASED PRIVATE CREDIT INVESTMENT FUND PER CONFIDENTIALITY PROVISIONS], a Delaware limited partnership, as administrative agent and collateral agent for each member of the Lender Group (in such capacity, together with its successors and assigns in such capacity, “Agent”) as sole lead arranger (in such capacity, together with its successors and assigns in such capacity, the “Sole Lead Arranger”) and sole book runner (in such capacity, together with its successors and assigns in such capacity, the “Sole Book Runner”), GLASS HOUSE BRANDS INC. a British Columbia corporation (“Parent”), MPB ACQUISITION CORP., a Nevada corporat
AMENDED AND RESTATED ACQUISITION AGREEMENTAcquisition Agreement • April 1st, 2022 • Glass House Brands Inc. • Medicinal chemicals & botanical products • British Columbia
This is the further amended plan of compromise, arrangement and reorganization of the Company, made pursuant to the Companies’ Creditors Arrangement Act.
